CRS Advances Nanobubble Technology Across Car Wash, Industrial and Healthcare Water Systems

Chemical Reduction Solutions LLC (CRS) is proud to announce significant progress across several major initiatives involving car wash water treatment, industrial membrane filtration, building-water biofilm control and independent laboratory validation.

Together, these advancements demonstrate the expanding potential of CRS’s nanobubble technology to improve water-system performance across a wide range of commercial and industrial applications.

NanoSoft™ Adoption Accelerates in the Car Wash Industry

NanoSoft™, CRS’s nanobubble-powered alternative to conventional salt-based water softening, continues to gain significant attention throughout the professional car wash industry.

Every NanoSoft trial location to date has converted into a paying customer, and interest from car wash operators, equipment providers and chemical suppliers continues to accelerate.

In addition to eliminating or materially reducing the cost, labor and water consumption associated with salt-based softeners, NanoSoft customers are reporting improved reverse osmosis system performance and reductions in overall water waste of up to 10%.

Unlike a conventional water softener, NanoSoft does not rely on salt regeneration or discharge chloride-heavy brine. Instead, it conditions the water using CRS’s hydrodynamic cavitation-based nanobubble technology, helping operators use water more efficiently while protecting the performance of downstream RO equipment.

For car wash operators, the result is a simpler and more sustainable approach to water treatment—without sacrificing wash quality or RO performance.

CRS Launches Hydroxyl™ for Industrial Membrane Pretreatment

CRS has officially launched Hydroxyl™, an industrial membrane pretreatment system designed to help mitigate biological fouling in pretreatment filters and membrane-filtration systems.

Biological fouling can reduce membrane performance, increase differential pressure, shorten operating runs and contribute to more frequent filter changes, chemical cleanings and membrane replacement. Hydroxyl is designed to provide an additional layer of protection within the existing pretreatment stack.

The platform is initially focused on industries that rely heavily on membrane filtration, including:

• Desalination

• Pulp and paper manufacturing

• Bottled water and beverage production

• Semiconductor manufacturing

• Other high-volume industrial membrane applications

Rather than replacing an industrial facility’s existing pretreatment program, Hydroxyl is designed to enhance it by addressing biological fouling before it compromises filters, membranes and system economics.

Hydroxyl represents CRS’s expansion into some of the world’s most demanding water-treatment environments, where even modest improvements in membrane runtime, cleaning frequency and useful life can produce substantial operational savings.

LegionnX™ Targets Biofilm in Healthcare Building Water Systems

CRS has also launched LegionnX™, a main-water-line biofilm-mitigation system developed specifically for hospitals, senior living communities and other healthcare or elder care facilities.

Building plumbing systems can provide conditions that allow biofilm to develop inside pipes, fixtures and water-handling equipment. These biofilms can create protected harborage environments for opportunistic waterborne pathogens, including Legionella and Pseudomonas aeruginosa. The CDC recognizes both organisms as potential concerns in healthcare building water systems.

LegionnX is designed to continuously condition incoming water and inhibit biofilm development throughout a facility’s plumbing infrastructure. By targeting the underlying biofilm environment, LegionnX is intended to complement—not replace—a facility’s existing water-management, monitoring and disinfection protocols.

The objective is to give healthcare operators an additional, nonchemical tool for reducing biofilm accumulation and strengthening their overall building-water risk-management strategy.

Promising Initial Results From Montana State University

CRS has completed its first statement of work with Montana State University’s Center for Biofilm Engineering and has joined the Center’s Industrial Associate program. The Center for Biofilm Engineering is internationally recognized for its work involving the formation, behavior and control of biofilms across healthcare, environmental and industrial applications.

CRS is pleased to report that the initial results from this work are highly encouraging.

During a controlled five-day study, water conditioned using CRS’s nanobubble-generation technology exhibited a significant inhibitory effect on the growth of Pseudomonas aeruginosa compared with untreated chlorinated tap water.

At the conclusion of the test period, the nanobubble-conditioned water produced approximately 1,400-fold fewer culturable bacteria, as measured through colony-forming unit counts.

Pseudomonas aeruginosa is a well-established biofilm-forming organism associated with plumbing and healthcare water systems. Once established within a biofilm, it can be difficult to control using conventional disinfection methods alone.

Although these findings are preliminary and additional testing is underway, the magnitude of the observed difference provides a compelling foundation for continued research into the ability of CRS technology to inhibit microbial growth and biofilm formation.

One Technology Platform, Multiple Water Challenges

From helping car wash operators eliminate salt-based softening to protecting industrial membranes and supporting healthcare water-management programs, CRS is developing practical applications for nanobubble technology across some of the most persistent and costly challenges in water treatment.

The common objective across each CRS platform is straightforward:

Use water more intelligently, improve equipment performance and make biological and mineral fouling easier to manage.

CRS looks forward to sharing additional field results, independent laboratory data and customer success stories as the NanoSoft™, Hydroxyl™ and LegionnX™ platforms continue to advance.